Cargando…

Impact of current and scaled‐up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings—what is required to achieve the WHO's HCV elimination targets?

AIMS: To estimate the impact of existing high‐coverage needle and syringe provision (HCNSP, defined as obtaining more than one sterile needle and syringe per injection reported) and opioid substitution therapy (OST) on hepatitis C virus (HCV) transmission among people who inject drugs (PWID) in thre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ward, Zoe, Platt, Lucy, Sweeney, Sedona, Hope, Vivian D., Maher, Lisa, Hutchinson, Sharon, Palmateer, Norah, Smith, Josie, Craine, Noel, Taylor, Avril, Martin, Natasha, Ayres, Rachel, Dillon, John, Hickman, Matthew, Vickerman, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	HCV Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175066/ https://www.ncbi.nlm.nih.gov/pubmed/29774607 http://dx.doi.org/10.1111/add.14217

Ejemplares similares

Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta‐analysis
por: Platt, Lucy, et al.
Publicado: (2017)

Modelling the impact of incarceration and prison‐based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland
por: Stone, Jack, et al.
Publicado: (2017)

Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS‐FANTASIO study)
por: Barré, Tangui, et al.
Publicado: (2019)

Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs
por: Platt, Lucy, et al.
Publicado: (2017)

The use of HCV positive donors among non-HCV infected liver transplant recipients
por: Zaffar, Duha, et al.
Publicado: (2022)

Non-epidemic HCV genotypes in low- and middle-income countries and the risk of resistance to current direct-acting antiviral regimens
por: Shah, Rajiv, et al.
Publicado: (2021)

Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons
por: Martin, Natasha K, et al.
Publicado: (2013)

Rapid Decline in HCV Incidence among People Who Inject Drugs Associated with National Scale-Up in Coverage of a Combination of Harm Reduction Interventions
por: Palmateer, Norah E., et al.
Publicado: (2014)

The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review
por: Gillies, Michelle, et al.
Publicado: (2010)

HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact
por: Martin, N K, et al.
Publicado: (2015)

Risk of HIV and Hepatitis B and C Over Time Among Men Who Inject Image and Performance Enhancing Drugs in England and Wales: Results From Cross-Sectional Prevalence Surveys, 1992–2013
por: Hope, Vivian D., et al.
Publicado: (2016)

Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy
por: Martin, Natasha K., et al.
Publicado: (2013)

A comparison of two biological markers of recent hepatitis C virus (HCV) infection: implications for the monitoring of interventions and strategies to reduce HCV transmission among people who inject drugs
por: Hope, Vivian D, et al.
Publicado: (2018)

HCV elimination among people who inject drugs. Modelling pre- and post–WHO elimination era
por: Gountas, Ilias, et al.
Publicado: (2018)

Prison‐based interventions are key to achieving HCV elimination among people who inject drugs in New South Wales, Australia: A modelling study
por: Stone, Jack, et al.
Publicado: (2022)

The cost‐effectiveness of testing for NS5a resistance‐associated polymorphisms at baseline in genotype 1a‐infected (treatment‐naïve and treatment‐experienced) subjects treated with all‐oral elbasvir/grazoprevir regimens in the United States
por: Elbasha, E. H., et al.
Publicado: (2016)

Impact of HCV Testing and Treatment on HCV Transmission Among Men Who Have Sex With Men and Who Inject Drugs in San Francisco: A Modelling Analysis
por: Artenie, Adelina, et al.
Publicado: (2023)

Infections with Spore-forming Bacteria in Persons Who Inject Drugs, 2000–2009
por: Palmateer, Norah E., et al.
Publicado: (2013)

Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs
por: Yeung, Alan, et al.
Publicado: (2022)

HCV incidence is associated with injecting partner age and HCV serostatus mixing in young adults who inject drugs in San Francisco
por: Page, Kimberly, et al.
Publicado: (2019)

Scaling up screening and treatment for elimination of hepatitis C among men who have sex with men in the era of HIV pre-exposure prophylaxis
por: Macgregor, Louis, et al.
Publicado: (2019)

DigiPrEP: A Pilot Trial to Evaluate the Feasibility, Acceptability, and Accuracy of a Digital Pill System to Measure PrEP Adherence in Men Who Have Sex With Men Who Use Substances
por: Chai, Peter R., et al.
Publicado: (2022)

Modeling the role of incarceration in HCV transmission and prevention amongst people who inject drugs in rural Kentucky
por: Stone, Jack, et al.
Publicado: (2020)

Infused Therapy and Survival in Older Patients Diagnosed with Metastatic Breast Cancer who Received Trastuzumab
por: Griffiths, Robert I, et al.
Publicado: (2011)

Eliminate hepatitis: WHO
Publicado: (2017)

Can Hepatitis C Virus (HCV) Direct-Acting Antiviral Treatment as Prevention Reverse the HCV Epidemic Among Men Who Have Sex With Men in the United Kingdom? Epidemiological and Modeling Insights
por: Martin, Natasha K., et al.
Publicado: (2016)

The cost-effectiveness of an HCV outreach intervention for at-risk populations in London, UK
por: Ward, Zoe, et al.
Publicado: (2019)

Trends in Serosorting and the Association With HIV/STI Risk Over Time Among Men Who Have Sex With Men
por: Khosropour, Christine M., et al.
Publicado: (2016)

A systematic review of recommendations on screening strategies for breast cancer due to hereditary predisposition: Who, When, and How?
por: Cai, Yitong, et al.
Publicado: (2021)

High willingness to use drug consumption rooms among people who inject drugs in Scotland: findings from a national bio-behavioural survey among people who inject drugs
por: Trayner, Kirsten M.A., et al.
Publicado: (2021)

Years of life lived with disease and years of potential life lost in children who die of cancer in the United States, 2009
por: de Blank, Peter M, et al.
Publicado: (2015)

HPV‐vaccination and cancer cervical screening in 53 WHO European Countries: An update on prevention programs according to income level
por: Altobelli, Emma, et al.
Publicado: (2019)

Epidemiological trends, relative survival, and prognosis risk factors of WHO Grade III gliomas: A population‐based study
por: Fang, Jun‐Hao, et al.
Publicado: (2019)

Who Sends the Email? Using Electronic Surveys in Violence Research
por: Sutherland, Melissa A., et al.
Publicado: (2013)

Why does diabetic retinopathy happen, and how can we stop it?
por: Ockrim, Zoe
Publicado: (2011)

Employment as HIV Prevention: An Employment Support Intervention for Adolescent Men Who Have Sex With Men and Adolescent Transgender Women of Color
por: Hill, Brandon J., et al.
Publicado: (2022)

Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis
por: Stone, Jack, et al.
Publicado: (2018)

Pilot Outreach Program in Remedis—The Promising Step toward HCV Elimination among People Who Inject Drugs
por: Krekulová, Laura, et al.
Publicado: (2022)

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals
por: Martin, Natasha K, et al.
Publicado: (2013)

Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer
por: Elsayegh, Nisreen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sp47m3lvnqv2fmt5r2l41g2u9j